Access to Future Cures Act

HR 1170, the Access to Future Cures Act, would allow individuals to deduct the cost of storing their blood or related biomaterials (like stem cells) as a medical expense on federal income taxes. This directly affects patients who pay for such storage to potentially use in future medical treatments, such as stem cell therapies. The bill amends the tax code to explicitly include these storage costs under qualified medical expenses, which were previously excluded. The change would take effect after the bill is signed into law.